PSS9 - The Budget Impact of Introducing Ranibizumab in England and Wales for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
| Autor: | Malcolm, W.A., Leteneux, C., Claxton, L., Taylor, M., Rathi, H. |
|---|---|
| Zdroj: | In Value in Health November 2013 16(7):A503-A503 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect